xtandi
astellas pharma europe b.v. - enzalutamide - prostatiska neoplasmer - endokrin terapi - xtandi is indicated for:the treatment of adult men with metastatic hormone-sensitive prostate cancer (mhspc) in combination with androgen deprivation therapy (see section 5. the treatment of adult men with high-risk non-metastatic castration-resistant prostate cancer (crpc) (see section 5. the treatment of adult men with metastatic crpc who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated (see section 5. the treatment of adult men with metastatic crpc whose disease has progressed on or after docetaxel therapy.
hydrocortisone aceponate ecuphar (previously cortacare)
ecuphar - hydrokortisonacceponat - kortikosteroider, dermatologiska preparat - hundar - för symptomatisk behandling av inflammatoriska och pruritiska dermatoser hos hundar. for alleviation of clinical signs associated with atopic dermatitis in dogs.
byannli (previously paliperidone janssen-cilag international)
janssen-cilag international n.v. - paliperidonpalmitat - schizofreni - neuroleptika - byannli (previously paliperidone janssen-cilag international) a 6 monthly injection, is indicated for the maintenance treatment of schizophrenia in adult patients who are clinically stable on 1 monthly or 3 monthly paliperidone palmitate injectable products (see section 5.
suiseng diff/a
laboratorios hipra, s.a. - clostridioides difficile toxoid a, clostridioides difficile toxoid b, clostridium perfringens, type a, alpha toxoid - immunologicals for suidae, inactivated bacterial vaccines for pigs, clostridium - grisar - for the passive immunisation of neonatal piglets by means of the active immunisation of breeding sows and gilts:- to prevent mortality and reduce clinical signs and macroscopic lesions caused by clostridioides difficile toxins a and b. - to reduce clinical signs and macroscopic lesions caused by clostridium perfringens type a, alpha toxin.
mykofenolatmofetil orifarm 250 mg kapsel, hård
orifarm ab - mykofenolatmofetil - kapsel, hård - 250 mg - natriumlaurilsulfat hjälpämne; propylenglykol hjälpämne; mykofenolatmofetil 250 mg aktiv substans
kagitz 400 mg depottablett
aristo pharma gmbh - kvetiapinfumarat - depottablett - 400 mg - kvetiapinfumarat 460,54 mg aktiv substans; laktosmonohydrat hjälpämne
kagitz 50 mg depottablett
aristo pharma gmbh - kvetiapinfumarat - depottablett - 50 mg - laktosmonohydrat hjälpämne; kvetiapinfumarat 57,568 mg aktiv substans
kagitz 300 mg depottablett
aristo pharma gmbh - kvetiapinfumarat - depottablett - 300 mg - kvetiapinfumarat 345,405 mg aktiv substans; laktosmonohydrat hjälpämne
tareg 160 mg filmdragerad tablett
paranova läkemedel ab - valsartan - filmdragerad tablett - 160 mg - valsartan 160 mg aktiv substans - valsartan
diovan 160 mg filmdragerad tablett
cross pharma ab - valsartan - filmdragerad tablett - 160 mg - valsartan 160 mg aktiv substans - valsartan